Sector: Pharmaceuticals & Biotechnology

Small Cap

Balaxi Pharma Share Price

BALAXI

₹23.71

0.13(0.55%)

22nd Jul 2026 | 1:14 PM

NSE : BALAXI

Open Free Demat Account

Balaxi Pharma Performance

Price Movement

₹23.71

₹23.58

₹24.20

↘ Today's Low↗ Today's High

1 Year Performance

₹23.71

₹15.20

₹52.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹24.20

Low₹23.58

Open at₹24.20

Prev Close₹23.58

Volumes10.81 K

Avg Price₹24.01

Lower Circuit₹22.41

Upper Circuit₹24.75

Historical Performance

3M High₹29.90

3M Low₹22.50

1 Yr High₹52.50

1 Yr Low₹15.20

3 Yr High₹151.45

3 Yr Low₹15.20

5 Yr High₹151.45

5 Yr Low₹15.20

Summary

As of 22-07-2026 13:47, Balaxi Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-23.58 (-100.00%) from the previous close of ₹23.58. The stock opened at ₹24.2 and traded between ₹23.58 and ₹24.2, with a total traded volume of 10810 shares. The company has a market capitalization of ₹132.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹52.5 and ₹15.2, respectively.

Balaxi Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 93.6, and book value of ₹0.50. Profitability indicators show ROE of 0.56%. Balaxi Pharmaceuticals Ltd. has reported revenue of ₹270.17 Cr and net profit of ₹1.42 Cr.

Balaxi Pharmaceuticals Ltd. technical indicators include Day RSI at 50.46, Day MFI at 44.66, Day ADX at 12.91. Additional indicators include Commodity Channel Index (CCI) at 32 and Williams %R at -47.69. Momentum indicators show Day MACD at -0.06, Day MACD Signal Line at -0.12, DayATR at 1.01. Rate of Change indicators for Balaxi Pharmaceuticals Ltd. include ROC125 at -6.97 and ROC21 at 1.48.

Exponential moving averages include EMA5 at ₹23.9, EMA10 at ₹23.9, EMA12 at ₹23.9, EMA20 at ₹23.9, EMA26 at ₹24, EMA50 at ₹24.1, EMA100 at ₹25, EMA200 at ₹30.2. Simple moving averages include SMA5 at ₹24, SMA10 at ₹24, SMA20 at ₹23.7, SMA30 at ₹23.7, SMA50 at ₹24.5, SMA100 at ₹23.2, SMA150 at ₹24.1, SMA200 at ₹28.2.

Support levels for Balaxi Pharma are placed at First Support ₹23.67, Second Support ₹23.32, Third Support ₹23.06. Resistance levels are seen at First Resistance ₹24.28, Second Resistance ₹24.54, Third Resistance ₹24.89. Balaxi Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 65.99%, FII holding at 0%, DII holding at 0%, public holding at 31.43%.

Balaxi Pharma Fundamentals

Market Cap

Below industry Median

132.60 Cr.

PE Ratio (TTM)

High in industry

93.60

Dividend Yield

Net Profit TTM

94% decr over last year

1.42

Net Profit Growth

94% decr over last year

1.42

PEG Ratio

Negative PEG TTM

-1

ROE

95% decr over last year

0.56

Operating Revenue TTM

270.17

Operating Revenue Growth

8% decr over last year

Book Value

Low in industry

0.50

MFI

MFI is mid-range

44.66

RSI

RSI is mid-range

50.46

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.50

Balaxi Pharma Financials

Data not available for chart

Indicator
No Record Found

Balaxi Pharma Technicals

Balaxi Pharmaceuticals Ltd. EMA & SMA

₹23.71

0.04 (0.17%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹23.9

Day EMA10 ₹23.9

Day EMA12 ₹23.9

Day EMA20 ₹23.9

Day EMA26 ₹24

Day EMA50 ₹24.1

Day EMA100 ₹25

Day EMA200 ₹30.2

Balaxi Pharma Support and Resistance

Resistance

First Resistance₹24.28

Second Resistance₹24.54

Third Resistance₹24.89

Support

First Support₹23.67

Second Support₹23.32

Third Support₹23.06

Technical Indicators

Day RSI50.46

Day MFI44.66

Day ADX12.91

Day Commodity Channel Index32.00

William-47.69

Day MACD-0.06

Day MACD Signal Line-0.12

Day ATR1.01

Day ROC125-6.97

Day ROC211.48

Balaxi Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	66	66	66	66	66	66
FII	16.5	16	8.9	3.5	1.7	0
DII	0	0	0	0	0.1	2.6
Public	17.5	18	25.1	30.5	32.2	31.4

Balaxi Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	14.58 K	14.58 K	100.00%
Week	26.16 K	26.16 K	100.00%
1 Month	26.42 K	26.42 K	100.00%
6 Month	70.82 K	92.32 K	76.71%

Balaxi Pharma SWOT Analysis

Strengths7

Weakness12

Opportunity1

Threats0

Price crossing above SMA20 today, and greater than SMA5

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Top Gainers

Balaxi Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Balaxi Pharma Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹140.50	₹551.10	₹5.10	₹109.90	₹167	₹14.92
% Change	0.32%	-1.47%	-0.58%	-0.54%	-0.55%	-2.93%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.88	₹27.81
PE TTM	66.80	-	-0.20	13.10	43.00	28.70
1 Year Return	0.54	44.87	426	-12.5	30.67	64.84
ROCE	-	3.56	-	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.40

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 297.00

-1.00%

MEDIORG

Medicamen Organics Ltd.

₹ 25.00

+4.17%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 531.00

-1.41%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-1.43%

SIGACHI

Sigachi Industries Ltd.

₹ 26.55

+2.00%

WINDLAS

Windlas Biotech Ltd.

₹ 862.15

-2.08%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.24

-2.05%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 531.55

-4.88%

ZIMLAB

Zim Laboratories Ltd.

₹ 118.57

-0.01%

MEDICO

Medico Remedies Ltd.

₹ 37.60

-2.64%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 186.35

-2.02%

LASA

Lasa Supergenerics Ltd.

₹ 7.28

-0.27%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 315.90

-1.70%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 323.35

-12.45%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.85

-0.80%

BROOKS

Brooks Laboratories Ltd.

₹ 67.07

+1.07%

RPGLIFE

RPG Life Sciences Ltd.

₹ 3001.00

+0.10%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 238.25

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 67.39

-0.37%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 385.30

-0.75%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.60

-0.93%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.41

+0.55%

INDOCO

Indoco Remedies Ltd.

₹ 235.99

-4.01%

FAQ's on BALAXI

What is the Market Capitalization of Balaxi Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Balaxi Pharmaceuticals Ltd. is approximately ₹ 132.6 Cr.

What are the PE and PB ratios for Balaxi Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Balaxi Pharmaceuticals Ltd. is 93.6, and the Price-to-Book (PB) ratio is 0.5.

What is the 52-Week High and Low for Balaxi Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Balaxi Pharmaceuticals Ltd. shares was ₹ 52.5, and the lowest price was ₹ 15.2.

Who are the major shareholders of Balaxi Pharmaceuticals Ltd.?

Significant shareholdings in Balaxi Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Balaxi Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Balaxi Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy